2012
DOI: 10.4046/trd.2012.72.3.318
|View full text |Cite
|
Sign up to set email alerts
|

A Case of Capecitabine-Induced Sarcoidosis

Abstract: Sarcoidosis is an inflammatory disease involving multiple-organs with an unknown cause. The new onset of sarcoidosis associated with therapeutic agents has been observed in 3 clinical settings; tumor necrosis factor antagonists in autoimmune rheumatologic diseases, interferon alpha with or without ribavirin in patients with chronic hepatitis C or melanoma, and antineoplastic agent-associated sarcoidosis in patients with hematologic malignancies. Here, we report a female patient who developed sarcoidosis after … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
3
1
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 14 publications
0
4
0
Order By: Relevance
“…Our patient did not receive a bone marrow transplant, but she was treated with several chemotherapeutic agents as part of the clinical trial. Granulomatous disease has been associated with exposure to chemotherapy agents, for example, capecitabine, interferon beta, and particularly heavy metals or methotrexate [7, 8]. It is not clear whether this was a factor in the case presented here.…”
Section: Discussionmentioning
confidence: 97%
“…Our patient did not receive a bone marrow transplant, but she was treated with several chemotherapeutic agents as part of the clinical trial. Granulomatous disease has been associated with exposure to chemotherapy agents, for example, capecitabine, interferon beta, and particularly heavy metals or methotrexate [7, 8]. It is not clear whether this was a factor in the case presented here.…”
Section: Discussionmentioning
confidence: 97%
“…It does not fall into the four drug categories that cause sarcoid-like reactions in the literature (6, 10). However, a case of capecitabine-associated sarcoidosis in a patient with colorectal cancer has previously been reported in the literature (7). Our case is the rst case that developed sarcoidosis due to adjuvant capecitabine used in breast cancer treatment.…”
Section: Discussionmentioning
confidence: 82%
“…It is used in breast cancer and colorectal cancer treatments due to its effectiveness, reliability and good tolerability (5,6). To this date there is only one reported case of sarcoidosis that developed after capecitabine treatment in a patient diagnosed with colon cancer (7). Here, we aimed to present a case of sarcoidosis that developed after adjuvant capecitabine treatment in a patient diagnosed with breast cancer.…”
Section: Introductionmentioning
confidence: 99%
“…[7] Capecitabine and FOLFOX were found to be associated with sarcoidosis and/or granulomatous reactions in previous publications, suggesting a possible explanation of mechanism in our case, as well. [1415]…”
Section: Discussionmentioning
confidence: 99%